EMILIA
CERCENADO MANSILLA
Profesora asociada de Ciencias de la Salud
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (13)
2023
-
Epidemiology and clinical features of Streptococcus pyogenes bloodstream infections in children in Madrid, Spain
European Journal of Pediatrics, Vol. 182, Núm. 7, pp. 3057-3062
2018
-
Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations
Transplantation Reviews, Vol. 32, Núm. 1, pp. 36-57
2017
-
Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 12, pp. 3283-3287
-
The carbapenemase-producing Klebsiella pneumoniae population is distinct and more clonal than the carbapenem-susceptible population
Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 4
2016
-
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
Journal of Infection, Vol. 72, Núm. 2, pp. 152-160
2013
-
Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases
Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 5, pp. 1054-1059
2012
-
Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH
Farmacia Hospitalaria, Vol. 36, Núm. 1
-
Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 1
2011
-
Programs to optimize antimicrobial use (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document
Medicina Preventiva, Vol. 17, Núm. 3, pp. 29-39
2010
-
AmpC β-lactamases in Escherichia coli: Emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131
Diagnostic Microbiology and Infectious Disease, Vol. 67, Núm. 3, pp. 270-276
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229
2006
-
Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions
Journal of Clinical Microbiology, Vol. 44, Núm. 7, pp. 2359-2366